netFormulary
 Report : A-Z HCD items in Formulary 13/06/2021 13:20:48
[Back]
 
Section Status HCD Name
08.01.05 Formulary Cancer Drugs Fund Abemaciclib Verzenios®
01.05.03 Formulary Cancer Drugs Fund Adalimumab 
11.08.02 Formulary Cancer Drugs Fund Aflibercept Eylea®
03.04.01 Non Formulary Cancer Drugs Fund alimemazine tartrate 
02.12 Formulary Cancer Drugs Fund Alirocumab Praluent®
10.01.03 Restricted Use Cancer Drugs Fund Apremilast Otzela®
13.05.02 Formulary Cancer Drugs Fund Apremilast Otezla®
04.02.01 Formulary Cancer Drugs Fund Aripiprazole 
09.08.01 Restricted Use Cancer Drugs Fund Asfotase alfa 
08.02.03 Formulary Cancer Drugs Fund Atezolizumab Tecentriq®
09.01.04 Formulary Cancer Drugs Fund Avatrombopag Doptelet®
08.02.03 Formulary Cancer Drugs Fund Avelumab Bavencio®
08.02.04 Formulary Cancer Drugs Fund Axicabtagene ciloleucel Yescarta®
13.05.03 Formulary Cancer Drugs Fund Baricitinib Olumiant®
10.01.03 Formulary Cancer Drugs Fund Belimumab 
08.01.01 Formulary Cancer Drugs Fund Bendamustine 
03.04.02 Formulary Cancer Drugs Fund Benralizumab Fasenra®
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade®
08.01.05 Formulary Cancer Drugs Fund Bosutinib Bosulif®
04.07.04.02 Formulary Cancer Drugs Fund Botulinum Toxin Type A Botox®
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris®
08.01.05 Formulary Cancer Drugs Fund Brigatinib Alunbrig®
11.08.02 Formulary Cancer Drugs Fund Brolucizumab Beovu®
08.01.05 Formulary Cancer Drugs Fund Cabazitaxel Jevtana®
04.08.01 Formulary Cancer Drugs Fund Cannabidiol Epidyolex®
08.02.03 Formulary Cancer Drugs Fund Caplacizumab Cablivi®
08.01.05 Formulary Cancer Drugs Fund Carfilzomib Kyprolis ®
08.01.01 Formulary Cancer Drugs Fund Carmustine Gliadel®
08.01.05 Formulary Cancer Drugs Fund Cemiplimab Libtayo®
08.01.05 Formulary Cancer Drugs Fund Ceritinib Zykadia®
10.01.03 Restricted Use Cancer Drugs Fund Certolizumab Pegol Cimzia®
08.01.03 Formulary Cancer Drugs Fund Cladribine Mavenclad®
08.01.05 Formulary Cancer Drugs Fund Crizotinib 
08.01.05 Formulary Cancer Drugs Fund Dabrafenib mesilate Tafinlar®
08.01.05 Formulary Cancer Drugs Fund Dacomitinib Vizimpro®
08.01.05 Formulary Cancer Drugs Fund Daratumumab  Darzalex®
08.03.04.02 Formulary Cancer Drugs Fund Darolutamide Nubeqa®
06.03.02 Formulary Cancer Drugs Fund Dexamethasone 
03.07 Formulary Cancer Drugs Fund Dornase Alfa Pulmozyme®
08.01.05 Formulary Cancer Drugs Fund Durvalumab Imfinzi®
09.01.04 Formulary Cancer Drugs Fund Eltrombopag  Revolade®
08.01.05 Formulary Cancer Drugs Fund Encorafenib  Braftovi®
08.01.05 Formulary Cancer Drugs Fund Entrectinib Rozlytrek®
04.07.04.02 Formulary Cancer Drugs Fund Erenumab Aimovig®
08.01.05 Formulary Cancer Drugs Fund Everolimus Afinitor®
02.12 Formulary Cancer Drugs Fund Evolocumab Repatha®
10.01.03 Formulary Cancer Drugs Fund Filgotinib Jyseleca®
04.07.04.02 Formulary Cancer Drugs Fund Fremanezumab Ajovy®
04.07.04.02 Formulary Cancer Drugs Fund Galcanezumab Emgality®
08.01.05 Formulary Cancer Drugs Fund Gilteritinib Xospata®
08.02.04 Formulary Cancer Drugs Fund Glatiramer acetate Copaxone®
05.03.03.02 Restricted Use Cancer Drugs Fund Glecaprevir - pibrentasvir Maviret®
01.05.03 Formulary Cancer Drugs Fund Golimumab Simponi®
10.01.03 Restricted Use Cancer Drugs Fund Golimumab Simponi®
13.05.03 Formulary Cancer Drugs Fund Guselkumab Tremfya®
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica ®
01.05.03 Formulary Cancer Drugs Fund Infliximab 
08.02.04 Formulary Cancer Drugs Fund Interferon Beta 
08.01.05 Formulary Cancer Drugs Fund Ipilimumab Yervoy®
08.02.03 Formulary Cancer Drugs Fund Isatuximab Sarclisa®
03.04.03 Formulary Cancer Drugs Fund Lanadelumab Takhzyro®
08.02.04 Formulary Cancer Drugs Fund Larotrectinib 
08.02.04 Formulary Cancer Drugs Fund Lenalidomide Revlimid®
08.01.05 Formulary Cancer Drugs Fund Lenvatinib Kisplyx®
05.03.02.02 Formulary Cancer Drugs Fund Letermovir Prevymis®
08.01.05 Formulary Cancer Drugs Fund Lorlatinib Lorviqua®
03.07 Formulary Cancer Drugs Fund Lumacaftor with ivacaftor Orkambi®
09.01.04 Formulary Cancer Drugs Fund Lusutrombopag Mulpleo®
08.03.04.03 Formulary Cancer Drugs Fund Lutetium (177Lu) oxodotreotide 
03.04.02 Restricted Use Cancer Drugs Fund Mepolizumab Nucala®
08.03.04.01 Formulary Cancer Drugs Fund Neratinib Nerlynx®
08.01.05 Formulary Cancer Drugs Fund Niraparib Zejula®
08.02.03 Formulary Cancer Drugs Fund Nivolumab Opdivo®
10.02 Formulary Cancer Drugs Fund Nusinersen® Spinraza
08.02.03 Formulary Cancer Drugs Fund Obinutuzumab  Gazyvaro®
08.02.03 Formulary Cancer Drugs Fund Ocrelizumab  Ocrevus®
08.01.05 Formulary Cancer Drugs Fund Olaparib Lynparza®
03.04.02 Restricted Use Cancer Drugs Fund Omalizumab 
08.01.05 Formulary Cancer Drugs Fund Osimertinib  Tagrisso ®
08.01.05 Formulary Cancer Drugs Fund Paclitaxel - Albumin Bound Formulation Abraxane®
08.01.05 Formulary Cancer Drugs Fund Palbociclib Ibrance®
08.02.04 Formulary Cancer Drugs Fund Peginterferon Beta-1a Plegridy®
08.02.03 Formulary Cancer Drugs Fund Pembrolizumab Keytruda®
07.04.03 Formulary Cancer Drugs Fund Pentosan polysulfate sodium Elmiron®
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta®
02.08.02 Non Formulary Cancer Drugs Fund Phenindione 
08.01.02 Formulary Cancer Drugs Fund Pixantrone Pixuvri®
08.02.03 Formulary Cancer Drugs Fund Polatuzumab vedotin Polivy®
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid®
09.02.01.01 Formulary Cancer Drugs Fund Potassium Chloride 
01.05.02 Non Formulary Cancer Drugs Fund Prednisolone enema 
11.08.02 Formulary Cancer Drugs Fund Ranibizumab Lucentis®
08.01.05 Formulary Cancer Drugs Fund Ribociclib Kisqali®
13.05.03 Formulary Cancer Drugs Fund Risankizumab Skyrizi®
09.01.04 Formulary Cancer Drugs Fund Romiplostim Nplate®
08.02.04 Formulary Cancer Drugs Fund Rucaparib Rubraca®
08.01.05 Formulary Cancer Drugs Fund Ruxolitinib Jakavi®
08.02.04 Formulary Cancer Drugs Fund Siponimod Mayzent®
08.01.05 Formulary Cancer Drugs Fund Talimogene laherparepvec Imlygic®
08.02.04 Formulary Cancer Drugs Fund Teriflunomide Aubagio®
08.02.04 Formulary Cancer Drugs Fund Thalidomide Celgene®
13.05.03 Formulary Cancer Drugs Fund Tildrakizumab Ilumetri®
01.05.03 Formulary Cancer Drugs Fund Tofacitinib Xeljanz®
10.01.03 Formulary Cancer Drugs Fund Tofacitinib  Xeljanz ®
08.01.05 Formulary Cancer Drugs Fund Trametinib Mekinist®
08.01.05 Formulary Cancer Drugs Fund Trastuzumab 
08.01.05 Formulary Cancer Drugs Fund Trastuzumab emtansine 
08.01.01 Formulary Cancer Drugs Fund Treosulfan Trecondi®
08.01.03 Formulary Cancer Drugs Fund Trifluridine tipiracil Lonsurf®
10.01.03 Formulary Cancer Drugs Fund Upadacitinib Rinvoq®
01.05.03 Formulary Cancer Drugs Fund Ustekinumab Stelara®
13.05.03 Formulary Cancer Drugs Fund Ustekinumab 
01.05.03 Formulary Cancer Drugs Fund Vedolizumab Entyvio®
South Staffordshire Joint Formulary